Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Clinical trial NCT00337389 · UNKNOWN

Trial details

NCT number: NCT00337389
Sponsor: Mast Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Colon Cancer Rectal Cancer

Start date: 2006-05-01
Enrollment: 1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.